UBS Group AG

Holdings History for Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0.01%	$52,535,166	2,117,073	+2,002,945	+1755%	$24.81	Q4 2025
30 Sep 2025	0%	-0%	$1,851,156	114,128	-56,854	-33%	$16.22	Q3 2025
30 Jun 2025	0%	-0%	$2,241,574	170,982	-72,914	-30%	$13.11	Q2 2025
31 Mar 2025	0%	+0%	$5,365,712	243,896	+151,830	+100%	$22.00	Q1 2025
31 Dec 2024	0%	+0%	$2,458,162	92,066	+16,761	+22%	$26.70	Q4 2024
30 Sep 2024	0%	+0%	$2,009,890	75,305	+14,795	+24%	$26.69	Q3 2024
30 Jun 2024	0%	-0%	$1,089,785	60,510	-13,608	-18%	$18.01	Q2 2024
31 Mar 2024	0%	+0%	$1,351,912	74,118	+74,118	NEW	$18.24	Q1 2024
31 Mar 2023		-0%	$0	0	-1,551	-100%	$28.47	Q1 2023
31 Dec 2022	0%	+0%	$13,866	1,551	+1,551	NEW	$8.94	Q4 2022
30 Jun 2022		-0%	$0	0	-22,047	-100%	$28.47	Q2 2022
31 Mar 2022	0%	+0%	$214,000	22,047	+22,047	NEW	$9.71	Q1 2022
30 Sep 2021		-0%	$0	0	-868	-100%	$28.47	Q3 2021
30 Jun 2021	0%	+0%	$19,000	868	+868	NEW	$21.89	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.